Indy

Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest globenewswire.com · about 16 hours ago

PN Smart Energy Limited Reports First Half 2026 Financial Results

NINGBO, China, Aug. 04, 2026 (GLOBE NEWSWIRE) -- PN Smart Energy Limited (“PN Smart” or the “Company”) (NASDAQ: PN), a global independent power producer (IPP) focused on the development of clean power stations, critical energy materials, and intelligent energy infrastructure, announced its financial results for the six months ended March 31, 2026. Financial Highlights Total revenue increased 5.5% YoY to approximately $25.5 million for the six months ended March 31, 2026, compared to approximately $24.2 million in the prior-year period.

Read full story ↗ Research PN

Press releases

More recent coverage

Page 49
KEY prnewswire.com · about 16 hours ago

KEYCORP CLOSES ACQUISITION OF CLEARWATER CORPORATE FINANCE LLP

CLEVELAND, Aug. 4, 2026 /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that it has completed its previously-announced acquisition of Clearwater Corporate Finance LLP ("Clearwater UK"), a leading UK-based middle market investment banking advisory firm. "Completing this acquisition marks an important step in expanding our global advisory platform," said Randy Paine, President of Key Institutional Bank.

Read source ↗
ERAS globenewswire.com · about 16 hours ago

MONDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - ERAS

SAN DIEGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the Erasca class action lawsuit. Captioned Cheng v.

Read source ↗
SYRA prnewswire.com · about 16 hours ago

Syra Health To Announce Second Quarter 2026 Financial Results

CARMEL, Ind., Aug. 4, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended June 30, 2026, on Tuesday, August 11, 2026.

Read source ↗
CAPR globenewswire.com · about 17 hours ago

CAPR INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”), have until September 28, 2026 to seek appointment as lead plaintiff of the Capicor class action lawsuit. Captioned Nkamga v.

Read source ↗
PLAB newsfilecorp.com · about 17 hours ago

Kaplan Fox Alerts Investors of Photronics, Inc. (PLAB) to a Pending Securities Class Action - Deadline is September 4, 2026

New York, New York--(Newsfile Corp. - August 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Photronics, Inc. ("Photronics" or the "Company") (NASDAQ: PLAB) on behalf of investors that purchased or otherwise acquired Photronics securities between December 10, 2025 and May 27, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Photronics and have suffered losses, you may CLICK HERE to contact us.

Read source ↗
BE globenewswire.com · about 17 hours ago

BE INVESTOR ALERT: Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026, both dates inclusive (the “Class Period”), have until September 28, 2026 to seek appointment as lead plaintiff of the Bloom Energy class action lawsuit. Captioned Nevins v.

Read source ↗
CRWV businesswire.com · about 17 hours ago

CoreWeave Expands Cloud AI Platform to Indonesia, Marking First Move Into Asia-Pacific Region

JAKARTA, Indonesia--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV), The Essential Cloud for AI™, today announced its expansion into Indonesia, the company's first data center presence in the Asia-Pacific region. The expansion adds three new facilities totaling 360 megawatts of contracted IT power, expected to come online in 2028. CoreWeave will own and operate the compute environment across all three sites, bringing its full AI cloud platform to labs, startups and enterprise customers deployin.

Read source ↗
YYGH prnewswire.com · about 17 hours ago

YY Group Acquires 95% Stake in Profitable Singapore-Incorporated Distributor

Bolt-on acquisition expected to contribute to Group revenue and net income in the first full quarter following completion SINGAPORE, Aug. 4, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), an AI-enabled workforce management platform and integrated facility management (IFM) provider operating across Asia and beyond, today announced that it has completed the acquisition of a 95% interest in Xtreme Solutions Pte. Ltd., an established Singapore-incorporated distributor (the "Target") for a total consideration of 4.5 million Singapore Dollars ("S$") (approximately US$3.5 million), payable through a combination of S$0.9 million in cash and Class A ordinary shares of the Company with an aggregate value of S$3.6 million, which will be subject to a 12-month lock-up period (the "Acquisition").

Read source ↗
NRG businesswire.com · about 17 hours ago

NRG Energy Reports Second Quarter 2026 Results and Reaffirms 2026 Financial Guidance

HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE: NRG) today announced financial results for the second quarter ended June 30, 2026, and reports GAAP Net Income of $506 million, GAAP Earnings per Share (EPS) — basic of $2.32, and GAAP Cash Provided by Operating Activities of $1,117 million. The Company's non-GAAP metrics are Adjusted Net Income of $315 million, Adjusted EPS of $1.49, Adjusted EBITDA of $1,217 million, and Free Cash Flow before Growth Investments (FCFbG) of $1,025 million for th.

Read source ↗
NTAP globenewswire.com · about 17 hours ago

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

CLEVELAND, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status for ZEVASKYN (prademagene zamikeracel) under the Fiscal Year 2027 Hospital Inpatient Prospective Payment System (IPPS) Final Rule. NTAP status provides supplemental CMS reimbursement above standard hospital payments to support access to innovative therapies like ZEVASKYN.

Read source ↗
NIOB globenewswire.com · about 17 hours ago

NIOB cuts target pegmatite in all Bardy holes

Vancouver, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (“NIOB” or the “Company”) has validated its radon targeting approach, after drilling at Bardy delivers a 100% hit rate for pegmatite dykes and a 75% hit rate for rare earth minerals. The pegmatite dykes were predicted from soil-gas radon anomalies at the Québec property.

Read source ↗
DDD globenewswire.com · about 17 hours ago

3D Systems Announces CEO Transition Plan

ROCK HILL, S.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE: DDD), a leading provider of additive manufacturing solutions, today announced a leadership transition plan in which Dr. Jeffrey Graves will step down as President and Chief Executive Officer and retire from the Board of Directors.

Read source ↗
CREX globenewswire.com · about 17 hours ago

Creative Realities, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call Information

LOUISVILLE, Ky., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended June 30, 2026 before the market open on Thursday, August 13, 2026.

Read source ↗
DEEP globenewswire.com · about 17 hours ago

DEEP SEA MINERALS CORP. FILES FORM F-10 REGISTRATION STATEMENT WITH U.S. SECURITIES AND EXCHANGE COMMISSION BECOMING A U.S. REPORTING COMPANY

Vancouver, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) ("Deep Sea Minerals" or the "Company"), a seabed mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to announce that it has filed a registration statement on Form F-10 (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”). The Registration Statement was filed under the multijurisdictional disclosure system established between Canada and the United States (“MJDS”) in connection with the Company's previously announced C$50 million short form base shelf prospectus.

Read source ↗
PVLA globenewswire.com · about 17 hours ago

Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

First module of the rolling NDA for QTORIN™ rapamycin for microcystic lymphatic malformations submitted to FDA, with completion of the NDA submission on track for the second half of 2026 Preparing for a planned standalone U.S. commercial launch of QTORIN™ rapamycin for microcystic lymphatic malformations in the first half of 2027, if approved Initiation of Phase 3 trial of QTORIN™ rapamycin for the treatment of cutaneous venous malformations planned for the fourth quarter of 2026 Initiation of Phase 2 trial of QTORIN™ pitavastatin for the treatment of disseminated superficial actinic porokeratosis planned for the second half of 2026 Topline results from the Phase 2 LOTU trial of QTORIN™ rapamycin for clinically significant angiokeratomas expected in the second half of 2027 Cash, cash equivalents and short-term investments of $250.6 million as of June 30, 2026 Company to host conference call at 8:30 a.m. ET today WAYNE, Pa.

Read source ↗
ZVRA globenewswire.com · about 17 hours ago

Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced that members of Zevra's executive leadership team will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 11:00 a.m. ET. Additionally, management will be available for one-on-one meetings with registered conference attendees.

Read source ↗
← Newer
Older →